临床药效学:药物反应原理与肾脏疾病中的改变
本文阐述药效学基本原理,区分受体介导的可逆效应与直接不可逆效应,以及浓度依赖性与时间依赖性抗菌药物。指出肾脏功能障碍时药物反应改变通常归因于药代动力学而非药效学,剂量调整计算默认药效学参数不变,但药效学同样重要,决定给药方案时应同时考虑两者。
要点
- 受体介导可逆效应有阈值和天花板浓度,不可逆效应仅受靶点数量限制。
- 浓度依赖性药物目标为高峰浓度,时间依赖性药物目标为谷浓度。
- 肾衰竭时药效学参数改变罕见报道,但决定剂量时需同时考虑药代与药效。
核心结论
- 肾脏疾病时药物反应改变多归因于药代动力学,药效学改变虽罕见但同样重要,决定给药方案应兼顾两者。
主要发现
- 可逆效应为容量限制且可饱和,不可逆效应仅受 viable 靶点数量限制。
- 浓度依赖性效应与高天花板浓度相关,目标为高峰浓度;时间依赖性效应与高阈值浓度相关,目标为高谷浓度。
- 肾脏功能障碍影响至少50%所有必需药物的药代动力学参数。
临床怎么用
- 肾脏病发现时临床医生常考虑药代动力学,但药效学同样重要。
- 有时将药效学概念纳入剂量决策过程需要意外的剂量调整。
- 确定任何给药方案时应同时考虑药代动力学和药效学。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pharmacokinetics and pharmacodynamics follow the logic of cause and consequence. Receptor-mediated and reversible effects can be distinguished from direct and irreversible effects. Reversible effects are capacity-limited and saturable whereas irreversible effects are limited only by the number of viable targets. In the case of receptor-mediated and reversible effects a threshold and a ceiling concentration can be defined. Antimicrobial drugs with concentration-dependent action are distinguished from drugs with time-dependent action. Concentration-dependent effects are associated with a high ceiling concentration and the target is the high peak. Time-dependent effects are associated with a high threshold concentration and the target is the high trough. During kidney dysfunction, alterations of drug response are usually attributed to pharmacokinetic but rarely to pharmacodynamic changes. Dose adjustment calculations, therefore, tacitly presume that pharmacodynamic parameters remain unchanged while only pharmacokinetic parameters are altered in kidney failure. Kidney dysfunction influences the pharmacokinetic parameters of at least 50% of all essential drugs. Clinicians usually consider pharmacokinetics when kidney disease is found, but pharmacodynamics is as important. Alterations of pharmacodynamic parameters are conceivable but only rarely reported in kidney failure. Sometimes surprising dosing adjustments are needed when pharmacodynamic concepts are brought into the decision process of which dose to choose. Pharmacokinetics and pharmacodynamics should both be considered when any dosing regimen is determined.
引用
- Keller F, Hann A. Clinical Pharmacodynamics: Principles of Drug Response and Alterations in Kidney Disease. Clin J Am Soc Nephrol. 2018. PMID: 29769182. doi:10.2215/CJN.10960917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。